Definitive Contract 75N95019C00026
- Not listed
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to Olink Proteomics AB, a foreign-owned for-profit organization, to provide Olink Biomarker Analysis Services. The $249,250.00 contract has a performance period through May 16, 2024 and does not have a set-aside designation. Olink Proteomics specializes in multiplex protein biomarker analysis platforms and has previously supported NIH, Food and Drug...
- This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute to the prime contractor Olink Proteomics AB, a foreign-owned for-profit organization. The contract is for $248,950.00 and is for the OLINK EXPLORE EXPANSION (4) requirement, which includes the provision of Olink's proprietary multiplex protein biomarker analysis technologies and platforms to support biomedical research. The contract has a firm fixed...
- This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of Olink Explore HT Reagent Kits, specialized biological and reagent materials used in advanced proteomics research. The contract has a ceiling value of $24,961.31 and a period of performance through September 17, 2025. Olink...
- This federal contract award, valued at $24,775.29, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company located in Waltham, Massachusetts. The contract requires Olink to provide proteomic kits to isolate and quantify proteins in plasma and bronchiole alveolar lavage samples. This is a firm fixed-price purchase order contract with a completion...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $203,298.48 firm fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, to provide OLINK EXPLORE HT REAGENT KITS. The contract has a completion date of April 24, 2024 and does not have a set-aside designation. The original pre-solicitation notice indicates that the National Institutes of Health National Institute on Drug Abuse is...
- This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Olink Proteomics AB, a foreign-owned for-profit company based in Sweden. The $69,388 contract is for Olink to provide laboratory services, specifically protein biomarker analysis using their proprietary multiplex platforms, to support NICHD's biomedical research across disease areas such as cancer, cardiovascular disease,...
- This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $14,531.69 contract is for the provision of Olink's proprietary proteomics instruments, reagent kits, integrated fluidic circuits, and analytical services to support biomedical research missions across the NIH, including aging, cancer, neurodegenerative diseases, diabetes, and infectious diseases. Olink...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $10,558 firm-fixed-price purchase order is for the delivery of Olink's proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical research missions spanning aging, cancer, neurodegenerative diseases, diabetes, infectious diseases, and more. Olink...
- The Department of Health and Human Services' National Institutes of Health awarded a firm-fixed-price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization, for $237,000 to provide Olink's proprietary proteomics reagent kits and array chips to support COVID-19 research. The award does not have a set-aside designation. Olink has previously provided similar proteomics services and reagents to federal agencies like the NIH, FDA, and VA to support research across disease...
- This is a firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $98,392.48 contract is for the delivery of the Olink Explore 3072 Proteomics Screening Kit, which supports the agency's biomedical research missions in areas such as aging, cancer, and neurodegenerative diseases. Olink Proteomics has a significant...
Olink Proteomics AB was awarded a firm fixed price, indefinite delivery contract valued at up to $1,214,788 by the National Institutes of Health National Institute on Drug Abuse to provide biological and reagent materials as well as proteomics analysis services. Specializing in proprietary multiplex protein biomarker analysis technologies, Olink will support biomedical research efforts through delivery of Olink Explore and Target multiplex protein analysis kits, reagents, array chips, and testing services enabling high-throughput quantification of proteins across thousands of samples. The contract has no set-aside designation. As a subcontractor, Olink will also perform sample preparation services for a prime contract held by Johns Hopkins University. Olink holds additional contracts with NIH and other federal agencies to provide circulating cancer biomarker analysis and other proteomics services in support of epidemiological studies and research into areas such as cancer, cardiovascular disease, and COVID-19.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($10k) | 2/21/24 | |
| P00001 | Other Administrative Action | $0 | 11/17/22 | |
| Not listed | Not listed | $1.2m | 5/31/19 |